EP2590626
LIPOSOMES WITH LIPIDS HAVING AN ADVANTAGEOUS PKA-VALUE FOR RNA DELIVERY
Anmelder
NOVARTIS AG [CH]GLAXOSMITHKLINE BIOLOG SA [BE]
Erfinder
GEALL ANDREW [US]
Externe Quellen
Klassifikation
IPC-Klassen
A61K 39/00A61K 9/127C12N 15/86
CPC-Klassen
A61K 31/7088A61K 39/00A61K 39/12A61K 9/127A61K 9/1272A61P 31/04A61P 31/10A61P 31/12A61P 31/14A61P 33/00A61P 35/00A61P 37/04A61P 43/00C12N 15/86
AI: Life Sciences
warum
Novartis/GSK lipid-nanoparticle vaccine — A61K39 + A61K9/127 + C12N15. Life Science.